| WHO classification of tumours of the central nervous system DN Louis (No Title), 2016 | 5344 | 2016 |
| Pathology and genetics of tumours of the nervous system. P Kleihues, WK Cavenee | 3070 | 2000 |
| DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2237 | 2018 |
| Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias W Stummer, HJ Reulen, T Meinel, U Pichlmeier, W Schumacher, JC Tonn, ... Neurosurgery 62 (3), 564-576, 2008 | 1236 | 2008 |
| Negative feedback loop of Wnt signaling through upregulation of conductin/axin2 in colorectal and liver tumors B Lustig, B Jerchow, M Sachs, S Weiler, T Pietsch, U Karsten, ... Molecular and cellular biology 22 (4), 1184-1193, 2002 | 1213 | 2002 |
| Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ... Acta neuropathologica 123, 473-484, 2012 | 1125 | 2012 |
| Long-term survival with glioblastoma multiforme D Krex, B Klink, C Hartmann, A Von Deimling, T Pietsch, M Simon, ... Brain 130 (10), 2596-2606, 2007 | 1107 | 2007 |
| Molecular classification of ependymal tumors across all CNS compartments, histopathological grades, and age groups KW Pajtler, H Witt, M Sill, DTW Jones, V Hovestadt, F Kratochwil, K Wani, ... Cancer cell 27 (5), 728-743, 2015 | 1089 | 2015 |
| Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre … R Stupp, ME Hegi, T Gorlia, SC Erridge, J Perry, YK Hong, KD Aldape, ... The lancet oncology 15 (10), 1100-1108, 2014 | 1019 | 2014 |
| NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide W Wick, C Hartmann, C Engel, M Stoffels, J Felsberg, F Stockhammer, ... Journal of clinical oncology 27 (35), 5874, 2009 | 964 | 2009 |
| Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the … C Hartmann, B Hentschel, W Wick, D Capper, J Felsberg, M Simon, ... Acta neuropathologica 120, 707-718, 2010 | 962 | 2010 |
| Treatment of early childhood medulloblastoma by postoperative chemotherapy alone S Rutkowski, U Bode, F Deinlein, H Ottensmeier, M Warmuth-Metz, ... New England Journal of Medicine 352 (10), 978-986, 2005 | 852 | 2005 |
| Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ... PloS one 3 (8), e3088, 2008 | 833 | 2008 |
| New brain tumor entities emerge from molecular classification of CNS-PNETs D Sturm, BA Orr, UH Toprak, V Hovestadt, DTW Jones, D Capper, M Sill, ... Cell 164 (5), 1060-1072, 2016 | 826 | 2016 |
| Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network M Weller, J Felsberg, C Hartmann, H Berger, JP Steinbach, J Schramm, ... Journal of Clinical Oncology 27 (34), 5743-5750, 2009 | 746 | 2009 |
| Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma PA Northcott, C Lee, T Zichner, AM Stütz, S Erkek, D Kawauchi, DJH Shih, ... Nature 511 (7510), 428-434, 2014 | 671 | 2014 |
| I nternational S ociety of N europathology‐H aarlem C onsensus G uidelines for N ervous S ystem T umor C lassification and G rading DN Louis, A Perry, P Burger, DW Ellison, G Reifenberger, A von Deimling, ... Brain pathology 24 (5), 429-435, 2014 | 669 | 2014 |
| High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial E Thiel, A Korfel, P Martus, L Kanz, F Griesinger, M Rauch, A Röth, ... The lancet oncology 11 (11), 1036-1047, 2010 | 661 | 2010 |
| NeuN: a useful neuronal marker for diagnostic histopathology. HK Wolf, R Buslei, R Schmidt-Kastner, PK Schmidt-Kastner, T Pietsch, ... Journal of Histochemistry & Cytochemistry 44 (10), 1167-1171, 1996 | 617 | 1996 |
| Risk stratification of childhood medulloblastoma in the molecular era: the current consensus V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ... Acta neuropathologica 131, 821-831, 2016 | 610 | 2016 |
Andreas WahaInstitut für Neuropathologie, Universitätsklinikum Bonnuni-bonn.de의 이메일 확인됨
